Tiratricol
Especificaciones
51-24-1Número CAS
200-086-1Número CE
2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acidNombre IUPAC
C14H9I3O4Fórmula química
621.93 g/molPeso molecular
Tiratricol; 51-24-1; 3,3',5-TRIIODOTHYROACETIC ACID; Triac; Triiodothyroacetic acid; Tiratricolum; Tiracana; 2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid; T3-acetic acid; DTXSID2045232; 2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)acetic acid; 3',3,5-Triiodothyroacetic acid; 3,5,3'-triiodothyroacetate; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodobenzeneacetic acid; NSC-759294; 29OQ9EU4R1; DTXCID0025232; 3,5,3'-triiodothyroacetic acid; RefChem:190125; D11AX08; H03AA04; 200-086-1; Teatrois; Tiratricol [INN]; Emcitate; Nidolin; MFCD00055931; 3,3',5-Triiodo Thyroacetic Acid; [4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid; Benzeneacetic acid, 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-; Triacana; CHEMBL41632; 2-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]acetic acid; CAS-51-24-1; NCGC00016227-01; Tiratricol, 3,3',5-triiodothyroacetic acid; [4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID; 3,3 inverted exclamation marka,5-Triiodothyroacetic acid; (4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)acetic acid; C14H9I3O4; 4HY; SMR000058684; T3A; SR-01000003135; Tiratricolum [INN-Latin]; Levothyroxine EP Impurity C; UNII-29OQ9EU4R1; Triax; UOWZUVNAGUAEQC-UHFFFAOYSA-N; Emcitate (TN); Tiracana (TN); Prestwick_439; EINECS 200-086-1; Tiratricol (Standard); 1nq0; TIRATRICOL [MI]; Prestwick0_000202; Prestwick1_000202; Prestwick2_000202; Prestwick3_000202; Tiratricol (USAN/INN); TIRATRICOL [USAN]; Triiodothyroacetic acid, 3; DES32736 (Dottikon); TIRATRICOL [MART.]; DIV08177 (DiverChim); TIRATRICOL [WHO-DD]; REGID_for_CID_5803; SCHEMBL25149; BSPBio_000183; MLS000028613; MLS006010657; SPBio_002104; 3,3,5-triiodothyroacetic acid; BPBio1_000203; GTPL2637; orb1224865; orb1308050; SCHEMBL30161572; BDBM18862; CHEBI:40021; HY-B1201R; 4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylacetic acid; GLXC-22117; HMS1568J05; HMS2095J05; HMS3264A05; HMS3652J07; HMS3712J05; HMS5082P06; MR-49; Pharmakon1600-01506047; HY-B1201; Tox21_110317; Tox21_303544; NSC759294; s4185; AKOS015951178; CCG-213970; CS-4829; DB03604; FT28502; NSC 759294; T3-ACETIC ACID [USP IMPURITY]; NCGC00016227-02; NCGC00016227-03; NCGC00016227-04; NCGC00016227-05; NCGC00016227-06; NCGC00016227-07; NCGC00016227-08; NCGC00257371-01; AS-15930; DA-58599; SY111973; 3,3',5-Triiodothyroacetic acid, >=90%; SBI-0207015.P001; NS00015686; SW196661-4; TRIIODOTHYROACETIC ACID [USP IMPURITY]; D07214; F787612; LEVOTHYROXINE SODIUM IMPURITY [USP IMPURITY]; LIOTHYRONINE SODIUM IMPURITY C [EP IMPURITY]; Q7809151; SR-01000003135-2; SR-01000003135-3; BRD-K61236135-001-03-3; BRD-K61236135-001-08-2; BRD-K61236135-001-09-0; LEVOTHYROXINE SODIUM IMPURITY C [EP IMPURITY]; Levothyroxine EP Impurity C; Liothyronine EP Impurity C; [(4-hydroxy-3-iodo-4-phenoxy)-3,5-diiodophenyl]acetic acid; 2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)aceticacid; Levothyroxine sodium impurity, triiodothyroacetic acid, or t3-acetic acid-; [4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic Acid (Triiodothyroacetic Acid)Sinónimos
